If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
638.00    -28.00 (-4.20%)
Bid:
702.00
Ask:
613.00
Spread: -89.00 (-12.678%)
Market Cap: £613.29m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Trading Update

29 Jul 2021 07:00

RNS Number : 8191G
discoverIE Group plc
29 July 2021
 

For Release

7.00am, 29 July 2021

discoverIE Group plc

 Trading Update

 

Strong organic growth in orders and sales over pre-Covid period

 

 

discoverIE Group plc (LSE: DSCV, "discoverIE" or the "Group"), a leading international designer, manufacturer and supplier of customised electronics to industry, today issues a trading update for the first three months of the year ending 31 March 2022.

 

The strong order growth reported in the second half of the last financial year continued in the first quarter this year, further strengthening the Group's order book. Revenue was significantly ahead of both the Covid-impacted prior year and the pre-Covid period of FY20202. With gross margins consistent with last year, and despite a stronger Sterling during the period3, the performance of the Group for the first quarter was ahead of the Board's expectations.

 

Group sales in the first quarter were 21% ahead of last year at CER3, growing by 16% organically4 and by 10% organically compared with two years ago. Organic performance was similar in both divisions and continues to be driven by demand in the Group's target markets5.

 

The order book at 30 June 2021 was £220m, 50% higher organically than last year and 30% higher organically than 2 years ago. Orders remained well ahead of sales, growing by 83% and 35% organically compared with last year and two years ago.

 

At the Group's facilities in India and Sri Lanka, production capacity has returned to near-normal levels despite ongoing local Covid-related social distancing restrictions. To satisfy future demand, the fit out of a new facility at our Nogales, Mexico site is underway which will double its production capacity and is on track to begin operations in the second quarter of this financial year.

The businesses of Phoenix and Limitor both acquired last year, and CPI, which was acquired in the first quarter this year, are making excellent progress and contributing well to the strong trading performance of the Group. Following the acquisition of CPI, gearing at the end of the first quarter has reduced to 1.2x (proforma gearing of 1.25x at 31 March 2021).

 

With a clear strategy focused on long-term high quality growth markets, a diversified customer base, a record order book and a strong pipeline of acquisition opportunities, the Group is well positioned to make further progress on its key priorities.

 

 

For further information, please contact:

 

discoverIE Group plc 01483 544 500

Nick Jefferies Group Chief Executive

Simon Gibbins Group Finance Director

 

Buchanan 020 7466 5000

Chris Lane, Toto Berger, Charlotte Slater

discoverIE@buchanan.uk.com

 

 

 

 

 

 

Notes

1. Growth rates refer to the comparable prior year period unless stated.

 

2. FY2020 is the year ended 31 March 2020.

 

3. Growth rates at constant exchange rates ("CER"). The average sterling rate of exchange strengthened 2% against the Euro compared with the average rate for last year and strengthened 13% against the US Dollar while weakening by 4% on average against the three Nordic currencies.

 

4. Organic growth for the Group compared with last year is calculated at CER and is shown excluding the first 12 months of acquisitions post completion (Phoenix was acquired in October 2020, Limitor in February 2021 an CPI in May 2021). Organic growth compared with two years ago excludes the first 24 months of acquisitions so also excludes Sens-Tech acquired in October 2019.

 

5. Target markets are renewable energy, medical, transportation and industrial & connectivity.

 

6. This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of discoverIE Group plc. It should not be relied on by any other party for other purposes. Certain statements made in this update are forward looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this update. Forward looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

 

Notes to Editors:

 

discoverIE Group plc is an international group of businesses that designs, manufactures and supplies innovative components for electronic applications.

 

The Group provides application-specific components to original equipment manufacturers ("OEMs") internationally. By designing components that meet customers' unique requirements, which are then manufactured and supplied throughout the life of their production, a high level of repeating revenue is generated with long term customer relationships.

 

With a focus on key markets driven by structural growth and increasing electronic content, namely renewable energy, medical, transportation and industrial & connectivity, the Group aims to achieve organic growth that is well ahead of GDP and to supplement that with targeted complementary acquisitions. The Group has an ongoing commitment to reducing the impact of its operations on the environment, while its key markets are aligned with a sustainable future.

 

The Group employs c.4,600 people and its principal operating units are located in Continental Europe, the UK, China, Sri Lanka, India and North America.

 

The Group is listed on the Main Market of the London Stock Exchange and is in the top quartile of the FTSE Small Cap Index, classified within the Electrical Components and Equipment subsector, and has revenues of over £450m.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFERDIITFIL
Date   Source Headline
30th Jan 20207:00 amRNSThird Quarter Trading Update
23rd Jan 20208:59 amRNSHolding(s) in Company
16th Jan 202010:57 amRNSHolding(s) in Company
23rd Dec 20199:26 amRNSHolding(s) in Company
9th Dec 20198:42 amRNSHolding(s) in Company
28th Nov 20197:00 amRNSHalf-year Report
19th Nov 20192:58 pmRNSDirector Declaration
23rd Oct 201910:44 amRNSHolding(s) in Company
23rd Oct 20199:01 amRNSHolding(s) in Company
17th Oct 20191:15 pmRNSResults of Placing
17th Oct 20197:00 amRNSAcquisition & Proposed Placing
10th Oct 20197:00 amRNSTrading Update
2nd Sep 20197:00 amRNSDirector Declaration
25th Jul 20191:38 pmRNSResult of AGM
25th Jul 20197:00 amRNSTrading Update
24th Jul 20199:00 amRNSIssue of Equity
10th Jul 201911:40 amRNSHolding(s) in Company
25th Jun 201911:31 amRNSAnnual Report and Accounts
4th Jun 20197:00 amRNSFinal Results
3rd May 20192:48 pmRNSHolding(s) in Company
1st May 20194:21 pmRNSDirector LTIP Award
30th Apr 20199:00 amRNSDirectorate Change
24th Apr 201911:21 amRNSHolding(s) in Company
18th Apr 201911:57 amRNSDirector/PDMR Shareholding
16th Apr 20191:08 pmRNSDirector Declaration
16th Apr 201911:35 amRNSResults of Placing
16th Apr 20197:01 amRNSAcquisitions & Proposed Placing
16th Apr 20197:00 amRNSTrading Update
18th Mar 20192:52 pmRNSHolding(s) in Company
15th Mar 20197:00 amRNSBoard and Committee Changes
8th Feb 20199:22 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSThird Quarter Trading Update
5th Dec 201810:12 amRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSHalf-year Report
17th Oct 20187:00 amRNSAcquisition
11th Oct 20187:00 amRNSTrading Update
10th Sep 20183:17 pmRNSIssue of Equity
22nd Aug 201811:30 amRNSHolding(s) in Company
26th Jul 20182:45 pmRNSResult of General Meeting
26th Jul 20182:40 pmRNSResult of AGM
26th Jul 20187:00 amRNSTrading Update
11th Jul 20182:17 pmRNSHolding(s) in Company
10th Jul 20187:00 amRNSPublication of Circular and Notice of EGM
26th Jun 20184:46 pmRNSAnnual Report and Accounts
19th Jun 20183:03 pmRNSIssue of Equity
11th Jun 201810:56 amRNSHolding(s) in Company
7th Jun 20184:08 pmRNSDirector/PDMR Shareholding
6th Jun 20189:00 amRNSExercise of share options
5th Jun 20187:00 amRNSFinal Results
19th Apr 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.